Plasmid Purification Made Easy

Nucleic acid purification procedures have enjoyed a long history, beginning with the first isolation of "nuclein" in 1869 by Freidrich Meischer. In 1958, Matthew Meselson and Frank Stahl demonstrated semiconservative replication of DNA using density-gradient centrifugation, an isolation method that became the cornerstone of recombinant DNA technology in the '70s and '80s. The technology was effective--producing high-quality DNA--but it was not efficient. The classical method of isolating pla

Written byHillary Sussman
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Nucleic acid purification procedures have enjoyed a long history, beginning with the first isolation of "nuclein" in 1869 by Freidrich Meischer. In 1958, Matthew Meselson and Frank Stahl demonstrated semiconservative replication of DNA using density-gradient centrifugation, an isolation method that became the cornerstone of recombinant DNA technology in the '70s and '80s. The technology was effective--producing high-quality DNA--but it was not efficient.

The classical method of isolating plasmid DNA from bacterial cells, called the alkaline lysis procedure, relies on density-gradient centrifugation.1 After incubating cells in an isotonic buffer, the cells are lysed in an alkaline solution containing detergent, which also denatures the DNA. Addition of a neutralizing solution--usually buffered potassium acetate--causes proteins and genomic DNA to crash out of solution, while the smaller plasmid DNA simply renatures, remaining in solution. The plasmid DNA is either ethanol precipitated or phenol-chloroform extracted, and then purified by cesium chloride-ethidium bromide density-gradient ultracentrifugation. The ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies